Your cart is currently empty!
GlaxoSmithKline Issues Recall for Nearly 600,000 Inhalers
GlaxoSmithKline (GSK) has announced a voluntary recall of approximately 593,000 prescription inhalers due to a potential defect in their delivery systems. This action, taken on April 4, affects units distributed across hospitals, pharmacies, retailers, and wholesalers in the United States.
The inhalers in question are the Ventolin HFA 200D type, as reported by the Asthma and Allergy Foundation of America. Although this recall is not directed at consumers, it is still crucial for users to verify whether their inhaler is among those affected, particularly the following lot numbers: 6ZP98486, ZP00036, and ZP9944.
The defect relates to the inhaler’s delivery mechanism. A GSK spokesperson indicated that the recall is precautionary, stemming from reports that the overwrap—the pouch enclosing the inhaler—could become inflated due to leaks. Such leaks could result in the inhaler delivering fewer doses than indicated, misleading users into thinking they have more medication available than they actually do.
GSK advises users not to return the inhalers. Instead, those with concerns about their inhaler’s functionality should reach out to the company’s response center. A GSK statement emphasized that while the benefit-risk assessment for Ventolin® HFA 200D remains favorable when used as directed, there is a risk of reduced effectiveness in cases of acute bronchospasm if users rely on a potentially faulty inhaler. GSK is dedicated to maintaining high-quality products and regrets any inconveniences this recall may cause.
To summarize, while the medication itself remains safe for use, the real concern lies in the possibility of users misjudging the amount of medication left due to leaking issues. The Asthma and Allergy Foundation of America has stated that this recall is unlikely to impact pharmacies’ supplies of Ventolin HFA 200D inhalers for those needing refills.
For further reading on similar topics, check out our other blog post on home insemination at this link. Additionally, for authoritative information on artificial insemination, visit Make a Mom. For comprehensive insights on infertility, Women’s Health is an excellent resource.